VBL Therapeutics announced an organizational streamlining designed to reduce operating expenses and preserve capital. As a result, VBL will reduce its workforce by approximately 35%. As part of the cost cutting initiatives, Dr. Ron Cohen, Dr. Bennett Shapiro and Ms. Alison Finger resigned from the board of directors, effective August 1, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.8708 USD | -4.66% | -8.34% | -53.93% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-53.93% | 7.85M | |
+17.73% | 123B | |
+16.88% | 111B | |
-9.04% | 23.63B | |
+4.40% | 22.58B | |
-38.15% | 17.61B | |
-7.75% | 17.6B | |
-15.36% | 17.26B | |
+3.42% | 13.55B | |
+29.63% | 11.34B |
- Stock Market
- Equities
- NTBL Stock
- News Notable Labs, Ltd.
- VBL Therapeutics Announces Executive Resignations